Nigel MacKenzie, Development Manager at Westcott, Dr Paul Bate, CEO of the UK Space Agency, Countess Howe, Lord-Lieutenant of Buckinghamshire, Alberto Garbayo, CEO of URA Thrusters, Councillor Steven ...
Chemical research environments are undergoing a profound transformation as modern laboratories confront rising demands for greater data throughput, more seamless integration of analytical and ...
Europe faces a critical challenge: The continent produces world-class science, but lacks behind other leading regions in translating discoveries into groundbreaking innovations that create jobs.
Sapio ELaiN applies the same security, auditability and data governance controls that underpin Sapio’s validated LIMS and lab informatics platform. All interactions with partner scientific ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modelling, and materials science. But ...
High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But ...
“Falcon H1R 7B marks a leap forward in the reasoning capabilities of compact AI systems,” said Dr Najwa Aaraj, CEO of TII. “It achieves near-perfect scores on elite benchmarks while keeping memory and ...
Advances in model optimisation and close collaboration with the open-source community mean that models previously confined to data centres can now run efficiently on a desktop system.
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with: Insights into HPC, AI, lab informatics & data Curated content for life ...
Oxford Drug Design’s lead compound demonstrated statistically significant anti-tumour activity with efficacy comparable to that of rapamycin.
At CES, Dassault Systèmes underscores its ambition to accelerate innovation toward a fully interoperable virtual human.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback